Price T Rowe Associates Inc Pa Vmed Inc. Transaction History

Price T Rowe Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.16 - $2.5 $28,650 - $61,747	-24,699 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.46 - $8.74 $3,444 - $12,236	-1,400 Reduced 5.36%	24,699 $61,000
Q3 2021 Nov 15, 2021	SELL	$5.1 - $9.39 $2,779 - $5,117	-545 Reduced 2.05%	26,099 $223,000
Q2 2021 Aug 16, 2021	SELL	$3.95 - $6.88 $145,277 - $253,039	-36,779 Reduced 57.99%	26,644 $171,000
Q1 2021 May 17, 2021	BUY	$2.01 - $5.55 $127,480 - $351,997	63,423 New	63,423 $282,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $74.6M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.